Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Development
Pharma
Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy
With Kai Beckmann now at the helm of Merck KGaA, the CEO is making his mark with a big outlay to support the German conglomerate’s life science arm.
Fraiser Kansteiner
Jun 25, 2026 9:56am
Eisai ends lorcaserin development in Dravet syndrome
Nov 18, 2024 10:18am
AstraZeneca trumpets new Calquence combos in CLL
Jul 29, 2024 10:25am
Nucleus RadioPharma unveils manufacturing pact with ARTBIO
May 7, 2024 8:47am
Cell therapy manufacturer Cellares draws $255M investment round
Aug 24, 2023 9:15am
Trial for controversial China-made Alzheimer's drug aborted
May 13, 2022 4:16pm
